Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduced Intensity Myeloablative Total Body Irradiation and Thymoglobulin Followed by Allogeneic Peripheral Blood Stem Cell Transplantation

NCT00709592 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT00709592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00709592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduced Intensity Myeloablative Total Body Irradiation and Thymoglobulin Followed by Allogeneic Peripheral Blood Stem Cell Transplantation
Lead sponsor
Virginia Commonwealth University
Phase
Phase 2
Overall status
Completed
Start date
July 21, 2008
Completion date
June 28, 2017
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, hodgkin lymphoma, leukemia, multiple myeloma, myelodysplastic syndrome, non-hodgkin's lymphoma